Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting human langerin promotes HIV-1 specific humoral immune responses

PLoS Pathogens(2021)10.1371/journal.ppat.1009749Source: DataRank Database

Targeting human langerin promotes HIV-1 specific humoral immune responses is a research paper published in PLoS Pathogens (2021). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.59)OA: goldTopics (77)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Aurélie Bouteau ORCID,Juliane S. Lanza ORCID,Adele Hammoudi,Sandra Zurawski,Mathieu Surénaud ORCID

Live enrichment

PubMed:34324611 PMC:PMC8354475 OpenAlex:https://openalex.org/W3184103583

Agence Nationale de la Recherche

Grant: ANR-10-LABX- 77-01

National Institutes of Health

Grant: NIH R01AI146420

agence nationale de recherche

Grant: ANR-10-LABX-77

NIAID NIH HHS

Grant: R01 AI146420

National Institutes of Health

Grant: 5R01AI146420-05

DC-subset-tailored vaccines

Baylor University

FWCI

0.59

Citation Percentile

0.6%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1371/journal.ppat.1009749

publisherhttps://doi.org/10.1371/journal.ppat.1009749

publisherhttps://dx.plos.org/10.1371/journal.ppat.1009749

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34324611

journalhttps://jdc.jefferson.edu/mifp/129

Fields of Study

Immunotherapy and Immune ResponsesT-cell and B-cell Immunologyvaccines and immunoinformatics approaches0301 basic medicine03 medical and health sciencesAIDS VaccinesAnimalsAntigens, CDHIV-1HumansImmunity, HumoralLangerhans CellsLectins, C-TypeLymphocyte ActivationMannose-Binding LectinsMiceenv Gene Products, Human Immunodeficiency Virus

MeSH Terms

AnimalsHumansLangerhans CellsLymphocyte ActivationHIV-1Antigens, CDAIDS VaccinesLectins, C-TypeMannose-Binding LectinsMiceenv Gene Products, Human Immunodeficiency VirusImmunity, Humoral

Keywords

Germinal centerLangerinImmunologyImmune systemAntigenBiologyAntibodyB cellMonoclonal antibodyFollicular dendritic cellsAntigen-presenting cellT cellVirologyDendritic cellQH301-705.5Medical Immunology610Mouse modelsQ1Lymphocyte ActivationAntibodiesT helper cellsMiceAntigens, CD616Cell differentiationAnimalsHumansLectins, C-TypeBiology (General)human langerinAIDS VaccinesDepartment of Microbiology and ImmunologyB cellsHIV vaccinesenv Gene Products, Human Immunodeficiency VirusRC581-607Immunity, Humoral[SDV] Life Sciences [q-bio]Mannose-Binding LectinsThomas Jefferson UniversityMedical MicrobiologyLangerhans CellsHIV-1CytokinesImmunologic diseases. Allergyhumoral immuneResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Targeting human langerin promotes HIV-1 specific humoral immune responses

FAIR Checklist

Authors (23)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)